Literature DB >> 32087497

Inhibiting NLRP3 inflammasome with MCC950 ameliorates perioperative neurocognitive disorders, suppressing neuroinflammation in the hippocampus in aged mice.

Qun Fu1, Jing Li2, Lili Qiu3, Jiaping Ruan1, Mingjie Mao1, Shuming Li3, Qinghong Mao4.   

Abstract

Perioperative neurocognitive disorders (PND) are characterized by deficits in cognitive functions in the elderly following anesthesia and surgery. Effective clinical interventions for preventing this disease are limited. Growing evidence demonstrates that activation of NOD-like receptor protein3 (NLRP3) inflammasome is involved in neurodegenerative diseases. We therefore hypothesized that activation of NLRP3 inflammasome is linked to neuroinflammation and the subsequent cognitive impairments that occurred in an animal model of PND. In this study, 18-month-old C57BL/6 mice were subjected to an exploratory laparotomy under isoflurane anesthesia to mimic clinical human abdominal surgery. For interventional studies, mice received NLRP3 specific inhibitor MCC950 (10 mg/kg) or the vehicle only intraperitoneally. Behavioral studies were performed at 6 and 7 d after surgery using open field and fear conditioning tests, respectively. Interleukin-1β (IL-1β), interleukin-18 (IL-18), tumor necrosis factor-α (TNF-α), ionized calcium-binding adaptor molecule-1 (IBA1) positive cells, glial fibrillary acidic protein (GFAP) positive cells, NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), and cleaved caspase-1 were measured at 3 days post-surgery. Brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95) were measured at 7 days post-surgery. Our data indicates that surgery-induced cognitive impairments were associated with significant increases in IL-1β, IL-18, TNF-α, NLRP3, ASC, cleaved caspase-1, IBA1-positive cells and GFAP-positive cells, and decreases in BDNF and PSD95 expression in the hippocampus. Notably, administration with MCC950 attenuated inflammatory changes and rescued surgery-induced cognitive impairments. Our study suggests that surgery induces neuroinflammation and cognitive deficits that are partly attributed to the activation of NLRP3 inflammasome in the hippocampus of aged mice.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aged; Cognitive impairment; NLRP3 inflammasome; Neuroinflammation; Perioperative neurocognitive disorders

Year:  2020        PMID: 32087497     DOI: 10.1016/j.intimp.2020.106317

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  13 in total

1.  Simultaneous Modulation of NLRP3 Inflammasome and Nrf2/ARE Pathway Rescues Thioacetamide-Induced Hepatic Damage in Mice: Role of Oxidative Stress and Inflammation.

Authors:  Durgesh Kumar Dwivedi; G B Jena
Journal:  Inflammation       Date:  2021-10-18       Impact factor: 4.092

Review 2.  'A picture is worth a thousand words': The use of microscopy for imaging neuroinflammation.

Authors:  Luciano Stürmer de Fraga; Isadora D'Ávila Tassinari; Jeferson Jantsch; Renata Padilha Guedes; Victorio Bambini-Junior
Journal:  Clin Exp Immunol       Date:  2021-10-10       Impact factor: 4.330

Review 3.  NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.

Authors:  Debashis Dutta; Jianuo Liu; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

Review 4.  The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases.

Authors:  Hallie M Blevins; Yiming Xu; Savannah Biby; Shijun Zhang
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

5.  Galectin-1 ameliorates perioperative neurocognitive disorders in aged mice.

Authors:  Zhiwen Shen; Hui Xu; Wen Song; Chuwen Hu; Mingyan Guo; Jinfeng Li; Junhua Li
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

6.  Harmine Ameliorates Cognitive Impairment by Inhibiting NLRP3 Inflammasome Activation and Enhancing the BDNF/TrkB Signaling Pathway in STZ-Induced Diabetic Rats.

Authors:  Peifang Liu; Hui Li; Yueqiu Wang; Xiaolin Su; Yang Li; Meiling Yan; Lan Ma; Hui Che
Journal:  Front Pharmacol       Date:  2020-05-01       Impact factor: 5.810

7.  Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats.

Authors:  Yang Liu; Huiqun Fu; Yan Wu; Binbin Nie; Fangyan Liu; Tianlong Wang; Wei Xiao; Shuyi Yang; Minhui Kan; Long Fan
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

8.  MicroRNA-138-5p Regulates Hippocampal Neuroinflammation and Cognitive Impairment by NLRP3/Caspase-1 Signaling Pathway in Rats.

Authors:  Xiaojin Feng; Jialing Hu; Fenfang Zhan; Deqiang Luo; Fuzhou Hua; Guohai Xu
Journal:  J Inflamm Res       Date:  2021-03-26

9.  Albiflorin Attenuates Mood Disorders Under Neuropathic Pain State by Suppressing the Hippocampal NLRP3 Inflammasome Activation During Chronic Constriction Injury.

Authors:  Pei Liu; Jianjun Chen; Shuai Ma; Jianjun Zhang; Jianyu Zhou
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

10.  The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.

Authors:  Wenyun Zeng; Danbin Wu; Yingxin Sun; Yanrong Suo; Qun Yu; Miao Zeng; Qing Gao; Bin Yu; Xijuan Jiang; Yijing Wang
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.